Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA for preserving cardiac function following infarction.

Liu J, Gu C, Cabigas EB, Pendergrass KD, Brown ME, Luo Y, Davis ME.

Biomaterials. 2013 May;34(14):3729-36. doi: 10.1016/j.biomaterials.2013.02.008. Epub 2013 Feb 19.

2.

Anti-apoptotic cardioprotective effects of SHP-1 gene silencing against ischemia-reperfusion injury: use of deoxycholic acid-modified low molecular weight polyethyleneimine as a cardiac siRNA-carrier.

Kim D, Hong J, Moon HH, Nam HY, Mok H, Jeong JH, Kim SW, Choi D, Kim SH.

J Control Release. 2013 Jun 10;168(2):125-34. doi: 10.1016/j.jconrel.2013.02.031. Epub 2013 Mar 14.

PMID:
23500061
3.

Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.

Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML.

Basic Res Cardiol. 2009 Nov;104(6):653-67. doi: 10.1007/s00395-009-0043-1. Epub 2009 Jul 9.

PMID:
19588183
4.

Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain.

Kim ID, Lim CM, Kim JB, Nam HY, Nam K, Kim SW, Park JS, Lee JK.

J Control Release. 2010 Mar 19;142(3):422-30. doi: 10.1016/j.jconrel.2009.11.011. Epub 2009 Nov 26.

PMID:
19944723
5.

Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers.

Tang Y, Li YB, Wang B, Lin RY, van Dongen M, Zurcher DM, Gu XY, Banaszak Holl MM, Liu G, Qi R.

Mol Pharm. 2012 Jun 4;9(6):1812-21. doi: 10.1021/mp3001364. Epub 2012 May 14.

6.

Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression.

Tadevosyan A, Maguy A, Villeneuve LR, Babin J, Bonnefoy A, Allen BG, Nattel S.

J Biol Chem. 2010 Jul 16;285(29):22338-49. doi: 10.1074/jbc.M110.121749. Epub 2010 May 12.

7.

Increased AT2R protein expression but not increased apoptosis during cardioprotection induced by AT1R blockade.

Moudgil R, Musat-Marcu S, Xu Y, Kumar D, Jugdutt BI.

Can J Cardiol. 2002 Aug;18(8):873-83. Corrected and republished in: Can J Cardiol. 2002 Oct;18(10):1107-16.

PMID:
12215750
8.

Dendrimers as carriers for siRNA delivery and gene silencing: a review.

Wu J, Huang W, He Z.

ScientificWorldJournal. 2013 Oct 29;2013:630654. doi: 10.1155/2013/630654. eCollection 2013. Review.

9.
10.

Angiotensin IV protects against angiotensin II-induced cardiac injury via AT4 receptor.

Yang H, Zeng XJ, Wang HX, Zhang LK, Dong XL, Guo S, Du J, Li HH, Tang CS.

Peptides. 2011 Oct;32(10):2108-15. doi: 10.1016/j.peptides.2011.09.015. Epub 2011 Sep 22.

PMID:
21963909
11.
12.
13.

Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer.

Liu X, Liu C, Laurini E, Posocco P, Pricl S, Qu F, Rocchi P, Peng L.

Mol Pharm. 2012 Mar 5;9(3):470-81. doi: 10.1021/mp2006104. Epub 2012 Jan 20.

PMID:
22208617
14.

Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.

Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A, Venturelli V, Schiavoni M, Lembo G, Volpe M.

Am J Hypertens. 2005 Apr;18(4 Pt 1):493-9.

PMID:
15831358
15.

High glucose enhances angiotensin-II-mediated peroxisome proliferation-activated receptor-gamma inactivation in human coronary artery endothelial cells.

Min Q, Bai YT, Jia G, Wu J, Xiang JZ.

Exp Mol Pathol. 2010 Feb;88(1):133-7. doi: 10.1016/j.yexmp.2009.09.011. Epub 2009 Sep 28.

PMID:
19796634
16.

Phospholipase C/protein kinase C pathway mediates angiotensin II-dependent apoptosis in neonatal rat cardiac fibroblasts expressing AT1 receptor.

Vivar R, Soto C, Copaja M, Mateluna F, Aranguiz P, Muñoz JP, Chiong M, Garcia L, Letelier A, Thomas WG, Lavandero S, Díaz-Araya G.

J Cardiovasc Pharmacol. 2008 Aug;52(2):184-90. doi: 10.1097/FJC.0b013e318181fadd.

PMID:
18670360
17.

In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.

Ofek P, Fischer W, Calderón M, Haag R, Satchi-Fainaro R.

FASEB J. 2010 Sep;24(9):3122-34. doi: 10.1096/fj.09-149641. Epub 2010 Apr 12.

18.

Splice variant-specific silencing of angiotensin II type 1a receptor messenger RNA by RNA interference in vascular smooth muscle cells.

Hassan A, Ji H, Zhang Y, Sandberg K.

Biochem Biophys Res Commun. 2006 Jan 13;339(2):499-505. Epub 2005 Nov 15.

PMID:
16307726
19.

Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.

Wang X, Khaidakov M, Ding Z, Mitra S, Lu J, Liu S, Mehta JL.

Exp Biol Med (Maywood). 2012 Dec;237(12):1394-401. doi: 10.1258/ebm.2012.012212.

PMID:
23354398
20.

[The effects of shRNA targeting angiotensin II type 1 receptor on blood pressure and AT1R mRNA expression in spontaneously hypertensive rats].

Xiao CS, Zhang JL, Qiu L.

Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Apr;35(4):354-8. Chinese.

PMID:
17711664
Items per page

Supplemental Content

Write to the Help Desk